Nuveen Asset Management, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$35,313,000
+4.1%
205,187
-24.1%
0.01%
+10.0%
Q2 2021$33,931,000
-8.1%
270,386
-0.7%
0.01%
-16.7%
Q1 2021$36,910,000
+2.9%
272,181
-2.9%
0.01%0.0%
Q4 2020$35,868,000
+56.6%
280,343
+37.7%
0.01%
+33.3%
Q3 2020$22,908,000
+61.3%
203,577
+36.6%
0.01%
+50.0%
Q2 2020$14,201,000
-58.3%
149,059
-60.7%
0.01%
-64.7%
Q1 2020$34,070,000
+234.1%
379,099
+97.1%
0.02%
+325.0%
Q4 2019$10,199,000
+33.8%
192,363
-0.3%
0.00%
+33.3%
Q3 2019$7,622,000
-4.5%
192,909
-0.7%
0.00%0.0%
Q2 2019$7,983,000194,3320.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders